Billiontoone (NASDAQ:BLLN) SVP Bosch John Roderick Ten Sells 1,416 Shares

Key Points

• Insider sale: SVP Bosch John Roderick Ten sold 1,416 Billiontoone shares for approximately $138,117 under a pre-arranged Rule 10b5-1 plan, reducing his ownership by 5.35% to 25,051 shares.
• Stock and financial performance: BLLN recently traded at $98.77, with a $4.66 billion market capitalization and a P/E ratio of 141.1. The company’s latest quarterly results matched analysts’ expectations at $0.15 EPS on $109.45 million in revenue.
• Analyst outlook is mixed: Seven analysts rate the stock Buy, two Hold, and two Sell, producing an overall “Hold” consensus and an average price target of $125.88; several firms recently lowered their targets, while Zacks downgraded the shares to “strong sell.”

Billiontoone, Inc. (NASDAQ:BLLN - Get Free Report) SVP Bosch John Roderick Ten sold 1,416 shares of the business's stock in a transaction on Wednesday, September 9th. The stock was sold at an average price of $97.54, for a total value of $138,116.64. Following the completion of the sale, the senior vice president directly owned 25,051 shares in the company, valued at $2,443,474.54. This trade represents a 5.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bosch John Roderick Ten also recently made the following trade(s):

• On Tuesday, August 25th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The stock was sold at an average price of $100.00, for a total transaction of $141,700.00.
• On Monday, August 10th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The shares were sold at an average price of $92.86, for a total transaction of $131,582.62.
• On Monday, June 29th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The shares were sold at an average price of $120.00, for a total value of $169,920.00.
• On Monday, June 15th, Bosch John Roderick Ten sold 2,832 shares of Billiontoone stock. The shares were sold at an average price of $101.47, for a total value of $287,363.04.

Billiontoone Stock Performance

Shares of Billiontoone stock traded up $0.26 during trading on Friday, hitting $98.77. 406,007 shares of the company's stock traded hands, compared to its average volume of 543,328. Billiontoone, Inc. has a 1 year low of $61.96 and a 1 year high of $150.44. The business has a 50-day simple moving average of $112.07 and a 200-day simple moving average of $95.79. The stock has a market capitalization of $4.66 billion and a P/E ratio of 141.10. The company has a debt-to-equity ratio of 0.17, a current ratio of 11.69 and a quick ratio of 11.31.

Billiontoone (NASDAQ:BLLN - Get Free Report) last posted its earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.15. The business had revenue of $109.45 million for the quarter. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. As a group, analysts forecast that Billiontoone, Inc. will post 0.83 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in BLLN. Rossby Financial LCC bought a new position in shares of Billiontoone in the fourth quarter worth about $25,000. Integrated Wealth Concepts LLC bought a new position in shares of Billiontoone during the 2nd quarter valued at approximately $29,000. MCF Advisors LLC increased its holdings in Billiontoone by 330.8% in the 2nd quarter. MCF Advisors LLC now owns 448 shares of the company's stock worth $54,000 after acquiring an additional 344 shares in the last quarter. Wells Fargo & Company MN purchased a new stake in Billiontoone in the 4th quarter worth approximately $76,000. Finally, Smartleaf Asset Management LLC bought a new stake in Billiontoone during the 4th quarter worth approximately $80,000.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. JPMorgan Chase & Co. dropped their target price on shares of Billiontoone from $145.00 to $130.00 and set an "overweight" rating on the stock in a report on Thursday, August 6th. Zacks Research cut Billiontoone from a "hold" rating to a "strong sell" rating in a report on Monday, August 31st. BTIG Research cut their price objective on Billiontoone from $142.00 to $130.00 and set a "buy" rating for the company in a report on Thursday, August 6th. Canaccord Genuity Group started coverage on Billiontoone in a report on Wednesday, September 2nd. They issued a "buy" rating and a $120.00 price objective for the company. Finally, Weiss Ratings raised Billiontoone from a "sell (d)" rating to a "sell (d+)" rating in a report on Tuesday, June 23rd. Seven analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have assigned a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $125.88.

About Billiontoone

BillionToOne, Inc is a molecular diagnostics company that develops blood-based tests designed to provide genetic and health information from small amounts of biological material. The company's technology uses its proprietary quantitative counting template approach to improve the accuracy and sensitivity of molecular testing.

The company's primary offerings include UNITY, a portfolio of prenatal genetic tests. These services support screening for chromosomal conditions, single-gene disorders and carrier status, and are designed to help healthcare providers assess fetal and maternal genetic risks using a maternal blood sample.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.